HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A double-blind controlled study of MK-486 in Parkinson's disease.

AuthorsA M Schwartz, C W Olanow, A Spencer
JournalTransactions of the American Neurological Association (Trans Am Neurol Assoc) Vol. 98 Pg. 301-3 ( 1973) ISSN: 0065-9479 [Print] United States
PMID4594189 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Antiparkinson Agents
  • Hydrazines
  • Placebos
  • Dihydroxyphenylalanine
  • Carbidopa
Topics
  • Aged
  • Anorexia Nervosa (etiology)
  • Antiparkinson Agents (adverse effects, therapeutic use)
  • Carbidopa (administration & dosage, adverse effects, therapeutic use)
  • Clinical Trials as Topic
  • Dihydroxyphenylalanine (administration & dosage, therapeutic use)
  • Evaluation Studies as Topic
  • Female
  • Humans
  • Hydrazines (therapeutic use)
  • Male
  • Middle Aged
  • Nausea (etiology)
  • Parkinson Disease (drug therapy)
  • Placebos

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: